In a study by Chakraborty et al. [58], alterations in the PIK3R1 in prostate cancer led to a high PI3K-AKT metabolic activity while reduced mRNA expression was observed in advanced stages of prostate cancer. This evidence concerns the gene PIK3R1 and prostate carcinoma.